The 27th annual National Biotechnology and Medicine Care Quality Award ceremony, along with the Symbol of National Quality (SNQ) certification, was held on January 16 at the banquet hall of the Grand Mayfull Hotel Taipei. Known as the highest honor in Taiwan's biotechnology and medical industries, the award encourages continuous quality enhancement in the sector and bolsters Taiwan's international reputation. This year, 31 teams were recognized, with 2 gold, 10 silver, and 19 bronze awards, while 358 teams earned the SNQ certification. The ceremony featured notable presenters, including Minister of Economic Affairs Jyh-Huei Kuo and Deputy Minister of Health and Welfare Jih-Haw Chou.
Top Winners in Healthcare Institutions
In the medical institutions category, the biggest winner was National Taiwan University Hospital (NTUH) and its Jinshan Branch, together earning 3 silver and 4 bronze awards. Close behind was the Taipei Veterans General Hospital (Taipei VGH) system, which secured 2 silver and 2 bronze awards.
During his speech, Wei-Chao Chen, the chief convener, emphasized that the gold, silver, and bronze awards are benchmarks of global, Asia-Pacific, and Taiwan leadership, identifying role models in Taiwan’s medical and biotech sectors. He highlighted Taiwan's continued achievement of international milestones and the establishment of global clinical guidelines.
Chen cited two examples of international-level accomplishments among this year’s winners. The first, the Tri-Service General Hospital cardiology team, won a silver award in the hospital specialty care category for developing an AI-driven electrocardiogram analysis system for clinical applications, reducing overall hospital mortality rates by 17%. Their system was even incorporated into European medical education guidelines. The second, Taipei VGH's pancreatic cancer treatment team, achieved breakthroughs in complex pancreaticoduodenectomy using Da Vinci robotic arms and was invited to author a surgical chapter in the international textbook Pancreas Cancer.
Gold Awards Highlight Precision Medicine and Innovative Care
This year’s two gold awards went to the Smart Care category in nursing services and the prescription drug category in pharmaceuticals. The former was awarded to Hualien Tzu Chi Medical Center for its "Intelligent Diabetes Care Program," which integrates AI-assisted care via the "Diabetes Health APP," ensuring comprehensive support for patients from admission to discharge. Recognizing the unique cultural needs of Indigenous patients in Hualien, the center also developed a Taroko language education system to overcome language barriers and provide accurate healthcare information.
In the prescription drug category, Novartis Taiwan earned the gold award for its intravenous suspension injection "Zolgensma," a groundbreaking one-time gene therapy for spinal muscular atrophy (SMA). Unlike lifelong drug regimens, this treatment repairs defective genes directly, offering new hope for infants with SMA. Its innovative manufacturing techniques and cold-chain logistics ensure treatment quality, revolutionizing care for affected children.
Four Key Trends Among Medical Institution Winners
Taipei VGH also won silver for its "AI Liver Cancer Recurrence Risk Prediction Project," developed in collaboration with National Yang Ming Chiao Tung University. This project employs AI algorithms to generate highly accurate predictions.
Bronze went to NTUH for its "Generative Disease Coding Assistance System," which uses a large language model trained on-site to improve the classification and coding of tens of thousands of diseases.
NTUH’s bronze-winning project utilized innovative techniques like duct-to-mucosa pancreaticojejunostomy and embolization to reduce complications, lowering the bleeding rate to 0.9% and 90-day mortality to 0.8%. They also developed the groundbreaking "Beyond Splenic Artery Pancreaticoduodenectomy" to improve post-surgery blood glucose control.
NTUH Jinshan Branch earned silver in the home care category with its "Person-Centered Continuous Home Care Model," which provides end-of-life care to patients and families under its "Aging in Place" philosophy.
The National Biotechnology and Medicine Care Quality Award continues to advance the goals of "upgrading biotechnology and pharmaceuticals" and "improving national health," while evolving with the times to address emerging challenges in healthcare and biotechnology.
Resource: 《國家生技醫療品質獎》31組團隊獲金銀銅獎,四大趨勢 展現亞洲生醫典範